The news reporters obtained a quote from the research from Mayo Clinic, "High costs of life-saving drugs are detrimental to both the personal finances of the individual patient, as well as society ...
Survival at five years was also significantly higher in the daratumumab group (93% vs. 86.9%). "These results are a major advancement in the treatment of high-risk smoldering multiple myeloma," says S ...
ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in ...
Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal plasma cells accumulate, they crowd out healthy cells and cause symptoms ...
MedPage Today on MSN
Managing health-related quality of life in multiple myeloma
Palliative care that recognizes patient goals and values is essential, starting at diagnos ...
MONDAY, Nov. 24, 2025 (HealthDay News) -- Patients with newly diagnosed multiple myeloma (NDMM) treated at a specialized clinic have improved outcomes, with median overall survival (OS) of 152 months, ...
Identifying risk factors enables physicians to implement targeted intervention strategies and preventive measures, aiming to reduce the disease burden and minimize the risk of relapse. Multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results